source
- Fortrea acquires Worldwide Clinical Trials' early-phase division for $45 millionFortrea announced it will purchase the early-phase services division of Worldwide Clinical Trials for $45 million. The transaction gives Fortrea control of Worldwide's clinical pharmacology unit,…
- Novartis to cut about 130 jobs in Switzerland as it reshapes biologics production in BaselNovartis announced it will eliminate roughly 130 positions in Switzerland as part of a reorganization of its biologics technical development and manufacturing footprint in Basel. The company plans…